Navigation Links
Novavax CEO to Present at Lazard Capital Markets 5th Annual Healthcare Conference
Date:11/12/2008

ROCKVILLE, Md., Nov. 12 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Lazard Capital Markets 5th Annual Healthcare Conference at 3:00 pm. (EST) on November 19, 2008 at the St. Regis Hotel, New York city. Dr. Singhvi will provide an overview of the company's strategy, research and development progress. A link to the live presentation can be accessed via the Company website at http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

ABOUT NOVAVAX

Novavax, Inc. (Nasdaq: NVAX) is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Novavax Announces Release Date of 2008 Third Quarter Financial Results and Investor Conference Call
2. Novavax CEO to Present at Oppenheimer 19th Annual Healthcare Conference
3. Novavax CEO to Present at BIO Investor Forum 2008
4. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
5. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
6. Novavax Announces Closing of $18 Million Registered Direct Offering
7. Novavax Announces Pricing of $18 Million Financing of Common Stock and Warrants
8. Novavax to Join Russell 3000 Index
9. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
10. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
11. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Vivakor, Inc. (OTC Bull...lders of record on December 1, 2009 will receive t...rica, Inc. that was previously approved by Vivakor... Nevada corporation of which Vivakor owned approxi... record date. The distribution date is still expec...
(Date:12/4/2009)...anced Micro Nano Technology Products (ACAMP) hosts..., Dec. 4 /PRNewswire/ - Today ACAMP hosted a healt...es like nanotechnology, biomaterials and microflui...nnovative healthcare products that help promote he... patient care, while opening new markets for Alber...
(Date:12/4/2009)...swire/ -- Stemline Therapeutics, Inc. today announ...3R targeting agents, SL-401 and SL-501, in both i...d leukemia (CML) have been selected for poster pre...he American Society of Hematology (ASH), to be hel...er will be presented by Stemline,s collaborators a...
(Date:12/4/2009)...PRNewswire-FirstCall/ -- BlueFire Ethanol Fuels, I...on changing the world,s transportation fuel paradi... cellulosic wastes, has been ranked number 19 on t...nies in Bioenergy;" the company,s second consecuti...BlueFire Ethanol among the top 20 bioenergy compan...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Alberta companies delivering new products to the health & medical marketplace 2Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4
...in Board: AGGX.OB) a New York-based biotechnology ...d anti-angiogenic drugs, announced the,appointment.... Dr. Garland,formerly with Hoffmann La Roche, Inc...for a number of early stage biotech companies such..., Lpath Therapeutics, Inc.,(LPTN.OB) and Tosk in a...
...fe, Inc. (NYSE: CRY ), and BioForm Medical, Inc. ...ceived a CE Mark for the use of CryoLife,s,BioGlue...ng endoscopic,browplasty or brow lift, a reconstru...val allows the product to be marketed in the Europ...by CryoLife,s partner BioForm Medical, for,use in ...
...nics Corporation,s (Amex: ETC ) ("ETC" or the "Co...d the sale of seven (7) BARA-MED(R) XD,Monoplace H...t at four (4),facilities associated with Haelen Hy...Hyperbarics, a growing network of,physician operat...n,Hyperbarics also provides physicians with turn-k...
Other Biology Technology:AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 2AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 3CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 2CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 3CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 4Environmental Tectonics Corporation's BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers 2Environmental Tectonics Corporation's BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers 3
(Date:12/4/2009)...ls constantly compete with one another for space a...s win this competition is well known to be the sur...or space and survival is not as clear. A study on ...cience by Johns Hopkins researchers describes how...around. , "Our work exemplifies how one signal c...
(Date:12/4/2009)...xas AgriLife Research plant physiologist at the Te...de, has been investigating ways to help vegetable ...reenhouse to the field. , "This research can aid...e further profitability of some vegetable crops by... will establish well," Leskovar said. "It could al...
(Date:12/4/2009)...analysis of statewide data taken from 1998-2001, w...ere more than three times likely to report they we...se of their insurance status during pregnancy and ...-based discrimination was also three times more li...r times more likely among women who did not have M...
Breaking Biology News(10 mins):Stem cells battle for space 2Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4Lower income women report more insurance-based discrimination during pregnancy, delivery 2EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 1EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 2ChemImage Works to Improve Existing Methods of Imaging Untreated Fingerprints on Paper Substrates 12460 1ChemImage Works to Improve Existing Methods of Imaging Untreated Fingerprints on Paper Substrates 12460 2Chicago area Infertility Specialist Richard Sherbahn MD Reports a Woman 26apos 3Bs Age Affects Her Chances of Successful Pregnancy from Egg Donation 47869 1Chicago area Infertility Specialist Richard Sherbahn MD Reports a Woman 26apos 3Bs Age Affects Her Chances of Successful Pregnancy from Egg Donation 47869 2Chicago area Infertility Specialist Richard Sherbahn MD Reports a Woman 26apos 3Bs Age Affects Her Chances of Successful Pregnancy from Egg Donation 47869 3Chicago area Infertility Specialist Richard Sherbahn MD Reports a Woman 26apos 3Bs Age Affects Her Chances of Successful Pregnancy from Egg Donation 47869 4
...IA (April 10, 2008) -- Monell Center scientist Mar...2008 Guggenheim Fellowship to pursue his work on d...are awarded to established scholars in the fields ...asis of distinguished achievement in the past and ...Selected from a pool of over 2,600 applicants, Fri...
...ach creates a dramatic improvement in cheap solar ...sing a popcorn-ball design tiny kernels clumped i... University of Washington are able to manipulate l...ting solar energy to electricity. The findings wil...l meeting of the American Chemical Society. , "W...
...lease is available in Spanish . , Researchers f...rnity tests regularly. Samples are usually collect...A analysis., The team of Dr Jos Antonio Lorente A...tification of the University of Granada ) carries...urt in cases of paternity tests, for the identific...
Other Biology News:Monell scientist Mark Friedman awarded Guggenheim Fellowship to study diet and obesity 2Popcorn-ball design doubles efficiency of dye-sensitized solar cells 2Fraud attempt in a paternity test modifies action protocol in DNA tests 2
Anti-JIP 1 / 2 (SH3) Polyclonal Antibody, Unconjugated, Clone ZMD.177 from Invitrogen
Mouse Anti-G-alpha-i 1 G-Protein Monoclonal Antibody, Unconjugated from AnaSpec
Rabbit Anti-oligophrenin-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-DAP Kinase 1 Monoclonal Antibody, Unconjugated, Clone DAPK-55 from Abcam
Biology Products: